FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1193586008: Product containing precisely etamsylate 250 milligram and tranexamic acid 250 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4687728012 Etamsylate 250 mg and tranexamic acid 250 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4687729016 Product containing precisely etamsylate 250 milligram and tranexamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4687728012 Etamsylate 250 mg and tranexamic acid 250 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4687729016 Product containing precisely etamsylate 250 milligram and tranexamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet Plays role Hemostatic therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet Has precise active ingredient Tranexamic acid (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet Has basis of strength substance (attribute) Tranexamic acid (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet Has precise active ingredient Etamsylate true Inferred relationship Existential restriction modifier (core metadata concept) 2
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet Has basis of strength substance (attribute) Etamsylate true Inferred relationship Existential restriction modifier (core metadata concept) 2
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet Is a Etamsylate and tranexamic acid only product in oral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start